With help from AWS principal applied scientist Giacomo Bernardi and other colleagues, AWS has become the first company to ...
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study ...
Objective To perform a large-scale pairwise and network meta-analysis on the effects of all relevant exercise training modes on resting blood pressure to establish optimal antihypertensive exercise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results